Effects of the ACA on Health Care Cost Containment by Weiner, Janet, PhD, MPH et al.
University of Pennsylvania
ScholarlyCommons
Issue Briefs Leonard Davis Institute of Health Economics
3-2-2017
Effects of the ACA on Health Care Cost
Containment
Janet Weiner PhD, MPH
University of Pennsylvania, weinerja@mail.med.upenn.edu
Clifford Marks
Univeristy of Pennsylvania, cmarks@mail.med.upenn.edu
Mark Pauly PhD
University of Pennsylvania, pauly@wharton.upenn.edu
Follow this and additional works at: http://repository.upenn.edu/ldi_issuebriefs
Part of the Health Economics Commons
LDI briefs are produced by LDI's policy team. For more information please contact Janet Weiner at weinerja@mail.med.upenn.edu.
This paper is posted at ScholarlyCommons. http://repository.upenn.edu/ldi_issuebriefs/113
For more information, please contact repository@pobox.upenn.edu.
Weiner, Janet PhD, MPH; Marks, Clifford; and Pauly, Mark PhD. Effects of the ACA on Health Care Cost Containment. LDI Issue
Briefs. 2017; 21 (4). https://ldi.upenn.edu/brief/effects-aca-health-care-cost-containment
" >
https://ldi.upenn.edu/brief/effects-aca-health-care-cost-containment
Effects of the ACA on Health Care Cost Containment
Abstract
This brief reviews the evidence on how key ACA provisions have affected the growth of health care costs.
Coverage expansions produced a predictable jump in health care spending, amidst a slowdown that began a
decade ago. Although we have not returned to the double-digit increases of the past, the authors find little
evidence that ACA cost containment provisions produced changes necessary to “bend the cost curve.” Cost
control will likely play a prominent role in the next round of health reform and will be critical to sustaining
coverage.
gains in the long term.
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EFFECTS OF THE ACA 
ON HEALTH CARE COST 
CONTAINMENT
Janet Weiner, PhD, MPH, Clifford Marks, MD/MBA Candidate,  
and Mark Pauly, PhD
February 2017 . Vol. 21, No. 4
While the Affordable Care Act (ACA) has been largely defined by its coverage expansions, its 
authors recognized the need to include mechanisms to slow the growth of health care costs. The 
law’s provisions took aim at Medicare spending and to a lesser extent, factors that affect costs in 
the individual and group private market. To understand the law’s impact and potential to “bend 
the cost curve,” it is important to isolate the effects of the ACA from those attributable to the 
economic recession and recovery. Although the ACA’s future is in doubt, cost containment will 
remain a key ingredient of any health reform effort. In this brief, we discuss key ACA provisions 
and their effects on containing overall cost growth and the cost of ACA-related gains in coverage.
THE TRAJECTORY OF NATIONAL HEALTH SPENDING
First, let’s look at the big picture. As shown, national health expenditure (NHE) grows regardless 
of macroeconomic conditions, although this growth often slows in periods of recession. The 
historical patterns reflect slower growth due to cost containment efforts of managed care in the 
1990s; upturns from the managed care backlash and spending on blockbuster drugs in the early 
2000s; a deceleration through 2007 with a rapid rise of cheaper generic drugs and slower rate of 
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SUMMARY 
This brief reviews the evidence 
on how key ACA provisions have 
affected the growth of health 
care costs. Coverage expansions 
produced a predictable jump in 
health care spending, amidst a 
slowdown that began a decade 
ago.  Although we have not 
returned to the double-digit 
increases of the past, the authors 
find little evidence that ACA cost 
containment provisions produced 
changes necessary to “bend the 
cost curve.” Cost control will likely 
play a prominent role in the next 
round of health reform and will 
be critical to sustaining coverage 
gains in the long term.
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Figure 1
Growth in national health expenditures (NHE) and gross domestic product (GDP), and NHE as a share of GDP, 1989–2015. 
introduction of new technology; and a dramatic slowdown in growth through 2013, with a deep 
recession and modest recovery. The patterns also reflect the impact of the ACA, as large-scale 
coverage expansions began in 2014.
Why the dramatic slowdown from 2007-2013? Studies estimate that the 2007-2009 recession 
and the slow recovery from it explained somewhere between 37 percent and 70 percent of 
the slowdown. Others point to the spread of high-deductible health plans (HDHPs), which 
incentivize price-conscious consumers to shop for care and avoid low value care. Just four 
percent of employers offered HDHPs in 2005; by 2011, nearly a third of employers offered such 
plans. A 2013 study suggested that less generous benefit design might have accounted for 20 
percent of the slowdown. Slower adoption of expensive new medical technology and fewer new 
blockbuster drugs may have also been contributing factors.  
The ACA’s coverage expansion in 2014 spurred a spike in spending, as would be expected. These 
provisions allowed millions of people to get health insurance through the exchanges and through 
Medicaid expansion. Health care costs increased by 5.3 percent in 2014, from a low of 2.9 percent 
in 2013. The Office of the CMS Actuary estimated that increased use of health care services 
accounted for nearly 40 percent of the increase in per-capita health spending. Health costs 
grew by 5.8 percent in 2015, and preliminary estimates by the Altarum Institute indicate a steady 
growth rate of 5.4 percent over 2015.
Analysis of the ACA’s effects on cost containment rests on three concepts: first, that any 
provisions affecting only the individual market can have little effect on overall health spending, 
because only 6% of people under age 65 are in that market; second, that the slowing of the 
trajectory of health care spending predates the ACA and complicates analysis of its effects; 
and third, that while increased utilization of health care due to the ACA’s coverage expansion 
drove cost growth in the early years, health care prices will likely exert a powerful influence on the 
trajectory of health care costs over the long run. 
This point is brought home in a new analysis by the Office of the CMS Actuary, which projects 
that medical prices will account for an increasing share of cost growth as use and intensity of 
services decelerate, possibly due to meeting pent-up demand (Figure 2.) 
AS EXPECTED, THE ACA’S 
COVERAGE EXPANSIONS 
SPURRED A SPIKE IN SPENDING, 
AS USE OF HEALTH CARE 
SERVICES INCREASED.
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Source: Keehan et al., Health Affairs, 2017
Figure 2
 Factors Accounting for Actual and Projected Growth in Personal Health Care Expenditures 
In the following sections, we review key provisions in the ACA that target cost containment and 
what we know about their effects. 
KEY COST-CONTAINMENT PROVISIONS 
Medicare Reforms
One of the most immediate and direct ways that the ACA produced savings was through 
reductions in provider payment updates and Medicare Advantage (MA) payments. Prior to 
the ACA, payments to MA plans were 14 percent higher than the cost of covering similar 
beneficiaries under the traditional Medicare program, according to the Medicare Payment Advisory 
Commission. The ACA reduced payments to MA plans over six years, and by 2016, payments to 
MA plans were just two percent higher than costs in the traditional Medicare program. Although 
critics were concerned that these cuts would mean that plans withdrew from the program, according 
to Kaiser Family Foundation, enrollment actually increased from 24 percent in 2009 to 31 percent  
in 2016. The payment reductions produced short-term federal savings of $68 billion between 2011 
and 2016.  
The ACA provided a regulatory framework for containing costs in Medicare by setting a per 
capita target for spending growth and creating a 15-member Independent Payment Advisory 
Board (IPAB) to develop a plan to reduce spending if that target is exceeded. What the board 
can recommend is constrained: by law, it cannot raise premiums, reduce benefits, or increase cost 
sharing, meaning that their recommendations are mostly confined to cuts in provider payments. 
The board’s proposals become law unless Congress explicitly overrides them. Spending did not 
exceed per capita targets in the ACA’s first three years, and therefore IPAB was not triggered. The 
IPAB currently has no members, which reflects a congressional majority strongly opposed to its 
existence. IPAB has been targeted for repeal on a bipartisan basis and is not likely to survive as a 
cost containment mechanism.
Beyond IPAB, the ACA authorized multiple initiatives designed to wring savings out of Medicare 
through administrative simplification, improved quality, better care coordination, and reduced 
payment rates. Some of the most prominent examples include the Hospital Readmissions 
Reduction Program (HRRP); Accountable Care Organizations (ACOs) through the Medicare 
Shared Savings Program and Pioneer Program; primary care medical homes; and bundled payment 
models. This emphasis on moving to value-based reimbursement dovetails with changes in the 
Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which mandated that 
Medicare move from fee-for-service to alternative payment models, such as those with risk-sharing 
arrangements or reimbursement tied to quality measures.  
Early evidence from the HRRP has shown decreases in hospital readmissions, but no firm data on 
overall cost savings. According to an analysis by the Kaiser Family Foundation, for fiscal year 2017, 
79 percent of hospitals in the United States will receive a penalty and that penalty payments will 
total over half a billion dollars. 
Most of the ACA’s provisions promoting value-based payment were small-scale, voluntary 
programs that, at best, can be considered proof-of-concept demonstrations rather than cost 
containment initiatives. The programs have had variable effects on costs, and their ability to “bend 
the cost curve” remains conjecture. 
For example, the ACA promoted ACOs as both a quality improvement and cost containment 
mechanism. In 2015, more than 400 ACOs in the Pioneer ACO Model and the Medicare Shared 
MOST OF THE ACA’S 
PROVISIONS PROMOTING 
VALUE-BASED PAYMENT IN 
MEDICARE WERE SMALL-SCALE, 
VOLUNTARY PROGRAMS 
THAT, AT BEST, CAN BE 
CONSIDERED PROOF-OF-
CONCEPT DEMONSTRATIONS 
RATHER THAN COST 
CONTAINMENT INITIATIVES.
BRIEFIssueLDI
3
Savings Program generated $429 million in savings, but bonuses paid to high-performing ACOs 
produced a net loss of $216 million. ACOs with more experience tend to perform better over time. 
A recent study of the Comprehensive Primary Care Initiative (CPCI), a 2012 CMS initiative in 500 
practices to improve quality and reduce costs, found minimal effects on costs or outcomes after two 
years. The program did not generate enough savings in Medicare Parts A and B to cover care-
management fees associated with the program.  
In the most recent CMS evaluation, bundled payments also show modest effects on costs, 
depending on the model and clinical condition. In the most prevalent model, episode payments 
decreased spending for orthopedic surgery (mostly hip and knee replacements), but increased 
spending for spinal surgery, relative to comparison hospitals. These results were from voluntary 
programs; although CMS issued rules for a mandatory bundled payment system for heart attack 
treatment, bypass surgery, and surgical hip and femur fracture treatment in December 2016, the 
mandatory system may not survive a Republican administration and Congress that is opposed to it.
Private Market Insurance Reforms
The ACA includes a slew of new regulations affecting the private insurance market, both on and off 
the exchanges. These include a prohibition on lifetime and annual caps on coverage, a mandate to 
cover “essential health benefits,” premium rate review, and the Medical Loss Ratio (MLR) provision, 
which required insurers to provide a customer rebate if they spend too high a percentage of 
premium dollars on non-medical expenditures. It is difficult to tease out the countervailing effects of 
these regulations on health care costs, especially because the provisions affect the individual, small 
group, and large group markets differently. 
The most significant provision targeting long-term cost growth is the tax on high-cost health 
plans, known as the “Cadillac Tax”.  The provision imposes a 40 percent excise tax on high-cost, 
employer-sponsored insurance that was to begin in 2018. However, Congress voted to delay its 
implementation until 2020—an indication of the political difficulties of reining in health spending. 
Proponents predicted that this tax would spur employers to shift away from high-cost health 
insurance—long incentivized by preferential tax treatment—and in so doing drive down overall 
health care spending. Many unions, employer groups, and insurers continue to oppose the tax, 
however, and it remains unclear whether Congress will allow it to take effect.
In the individual market, the ACA focused on the creation and stability of exchanges as a way 
to promote competition and contain health care costs. Economic theory predicts, and evidence 
suggests, that a higher number of insurers in a marketplace correlates with lower premiums. But 
as we stated in a previous brief in this series, the exchanges have undergone significant turmoil in 
the past three years, and recent insurer departures have left some marketplaces with little or no 
competition. 
In the individual market, premium rate reviews were an explicit mechanism to restrain premium 
increases and keep costs down. An early analysis by Kaiser Family Foundation of the rate review 
provision found that 20 percent of filings resulted in lower premium increases due to the rate review 
process. On average, premium rate increases were 1.4 percentage points lower than originally 
requested.  Another analysis by the Department of Health and Human Services found that in 2013, 
rate review reduced premiums in the individual and small-group markets by almost $1 billion. The 
actual effects on health care costs, however, is unknown, given that insurers could have inflated 
premium increase requests above what would have been present in the absence of the provision.
Commonwealth Fund data on the effects of the medical loss ratio provision show that the law has 
had a modest effect on reducing premium overhead and providing consumer rebates. Insurers 
OF PRIVATE MARKET 
INSURANCE REFORMS, 
THE “CADILLAC TAX” HAS 
THE MOST POTENTIAL TO 
CURB LONG-TERM COST 
GROWTH, BUT HAS NOT 
BEEN IMPLEMENTED.
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reduced overhead spending by $350 million in 2011 and $1 billion in both 2012 and 2013. According 
to the Congressional Budget Office (CBO), rebates to customers, effectively lowering their 
premiums, totaled over $2.4 billion over the 2011 – 2014 period. The overall impact of the MLR 
provision on costs is uncertain, as insurers can reduce administrative costs or increase claims costs to 
avoid paying penalties.  
WHERE WE ARE AND WHAT WE DON’T KNOW
Much is unknown about the effects of various cost-containment provisions within the ACA. 
Depending on whether the ACA is repealed in total or pieces of it remain, we may not be able 
to determine what effects the law has had. To date, evidence has shown health spending has 
slowed since the ACA’s passage in 2010. However, as ACA coverage expansion provisions are 
implemented, we are seeing an increase in overall spending, although to an extent, that is to be 
expected. Medicare demonstrations around payment and delivery reforms are potentially useful 
in slowing cost growth, but they remain unproven and even the successful programs produce only 
modest savings.  In private insurance, provisions like rate review and MLR have had, at most, a 
minimal impact on overall health care costs.  
Outside of the ACA explicitly, high-deductible health plans and insurance mergers will likely have 
important effects on health spending, although the magnitude is hard to predict. Also in the mix are 
the long-term effects of changes in Medicare (particularly the role of IPAB), the Cadillac Tax, and 
the role of new technologies.    
Medicare. In 2015, the CMS Chief Actuary found that Medicare per-capita spending growth was 
just 0.12 percentage points below the trigger rate for IPAB to take effect. It is likely that the IPAB 
threshold of GDP + one percentage point will be hit in 2017.  Although it is highly unlikely that IPAB 
will survive, any mechanism that caps spending at this rate would force billions of dollars in savings.  
Cadillac Tax. The provision most likely to have a dramatic effect on premiums and curbing 
spending growth—the Cadillac Tax—remains years from implementation in the best-case scenario. 
Estimates of its explicit effects are varied. CBO and the Joint Committee on Taxation (JCT) 
recently estimated that in 2020, even if employers did not make any changes in response to the tax, 
five to ten percent of enrollees in ESI plans would be subject to the tax and that share would grow 
to between 15 and 20 percent in 2025.  If implemented as currently outlined under the law, CBO 
and JCT estimate that the tax will reduce deficits by nearly $80 billion by 2026.  
Some changes have occurred even though the tax has not been implemented. The 2016 Kaiser 
Employer Health Benefits Survey found that some employers have changed their plans’ coverage 
or increased cost sharing to avoid the tax. Another survey done by Mercer found that a significant 
number of respondents were taking steps that will limit their exposure to the tax. Forty-eight 
percent have implemented a consumer-directed health plan (CDHP), 38 percent have encouraged 
employees into CDHPs, 28 percent raised deductibles, and 17 percent dropped high-cost plans. 
A recent study found that consumer-directed health plans—combining high deductible plans with 
personal medical accounts—reduced health care spending significantly for firms offering CDHPs 
over three years.
Technology. The role of technology in accelerating health spending has been well established. 
While we do not know what new technologies are on the horizon, the current growth and 
proliferation of specialty drugs and new drug price increases suggest upward pressure will be 
exerted. New technologies can extend treatments to broader populations and improve life 
expectancy. They also can change the cost of treating patients, potentially increasing cost by 
BEYOND THE ACA, HIGH 
DEDUCTIBLE HEALTH PLANS, 
INSURANCE MERGERS, 
AND NEW TECHNOLOGIES 
ARE LIKELY TO HAVE 
IMPORTANT EFFECTS ON 
HEALTH SPENDING.
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providing more services, having a negligible effect through replacement, or decreasing utilization 
and potentially cost. The key challenge for policymakers is designing systems that promote cost-
effective technologies while reducing the use of expensive technologies that do little to improve 
outcomes. 
POLICY CONSIDERATIONS MOVING FORWARD
It is too early to draw firm conclusions about the ACA’s effect on cost containment, especially given 
that the provisions with the greatest potential impact— notably the Cadillac Tax and the IPAB —
have not been implemented. Still, the intense opposition to both provisions provides good reason 
to temper our expectations about the degree of cost containment we can achieve through the 
ACA alone. As the Trump Administration and Republican controlled Congress debate repealing 
or replacing the ACA, policymakers face a number of choices to reduce the growth of health care 
costs going forward.  
IPAB, as designed, has few proponents. In a comprehensive report, the Kaiser Family Foundation 
list a number of options for amending IPAB. These include modification to spending target and 
limits on savings targets, revising IPAB and Congressional consideration of proposals, and revising 
the scope of recommendations. But the idea of a per capita Medicare cap as a failsafe or backstop 
measure to contain costs remains on the table.
The Cadillac Tax incorporated a generally accepted economic principle—that preferential tax 
treatment encourages overconsumption of health care—in what appears to be a politically 
unacceptable way. Options to achieve the shared goals of the Cadillac Tax or make the tax more 
equitable could include a cap on the tax exclusion of health benefits, changing thresholds and 
indexing, and phasing in the tax over different income tiers. 
The climate for Congressional action on drug prices could dampen the impact of these 
technologies on overall health spending, although policy has proven difficult to enact in this area. 
Interventions aimed at reducing drug spending range from allowing the government to negotiate 
drug pricing, prohibit “pay for delay” arrangements, to allowing imported drugs from outside the 
United States. The recently passed 21st Century Cures Act will increase research funding and 
eventually lead to the development of more expensive new drugs, exerting upward pressure on 
overall health spending.
The long-term impact of the ACA on health care costs depends on several factors, chief among 
them whether the law is repealed or stripped down to its bare bones. If Congress continues to 
punt on the Cadillac Tax and repeals IPAB, the prospect of future cost containment may be bleak. 
Long-term trends in medical technology and new pharmaceuticals remain important unknowns, 
but the ACA does little to directly affect these drivers of health care cost growth. The ACA-driven 
payment and delivery innovations have thus far yielded modest cost savings. Ongoing trends in the 
employer market, such as the move toward consumer-directed health plans, might hold the most 
promise in the absence of more directed government policies.
The challenge to “bend the cost curve” remains an urgent one. The ACA provided needed 
coverage for millions of previously uninsured people, without a return to the double-digit spending 
increases of the past.  But the sustainability of these coverage gains, and extensions to the 
remaining uninsured, likely depend on implementation of cost containment measures that more 
directly, and forcefully, produce long-term changes in the growth of health care costs.  
WHETHER THE ACA IS 
REPEALED OR REPAIRED, 
SUSTAINING COVERAGE 
GAINS AND COVERING THE 
REMAINING UNINSURED WILL 
DEPEND ON OUR ABILITY TO 
“BEND THE COST CURVE”.
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